ClinicalTrials.Veeva

Menu

Clinical Procedures to Support Research in ALS (CAPTURE-ALS)

University of Miami logo

University of Miami

Status

Enrolling

Conditions

Primary Lateral Sclerosis
Amyotrophic Lateral Sclerosis
Progressive Muscular Atrophy
ALS-Frontotemporal Dementia

Study type

Observational

Funder types

Other
NIH

Identifiers

NCT03489278
U54NS092091 (U.S. NIH Grant/Contract)
20170785

Details and patient eligibility

About

The purpose of the Clinical Procedures To Support Research (CAPTURE) study is to utilize information collected in the medical record to learn more about a disease called amyotrophic lateral sclerosis (ALS) and related disorders.

Full description

The study will consent patients with ALS or related disorders that are receiving care at a clinical center in the CReATe consortium that uses Epic as its electronic health record (EHR) system. The study aims to systematically gather a clinical dataset through the EHR using a standardized approach to characterize the natural history of ALS and related diseases.

Enrollment

1,200 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Diagnosis of ALS or a related disorder (e.g. primary lateral sclerosis, progressive muscular atrophy).
  • Receiving care at a clinical center that uses Epic as its EHR.
  • Able and willing to provide informed consent (or informed consent obtainable from a designated proxy).

Exclusion criteria

  • Inability to understand English and/or Spanish

Trial design

1,200 participants in 1 patient group

Affected
Description:
Affected with ALS or a related disorder.

Trial contacts and locations

11

Loading...

Central trial contact

Michael Benatar, MBChB, MS, DPhil; Jessica Hernandez

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems